MSI-H And dMMR Market Report 2026
Download Free Sample Buy Now
MSI-H And dMMR Market Global Report 2026 Market Report Infographic Image
Item added to cart!

Published : February 2026

Pages : 200

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF
Purchase This Report

MSI-H And dMMR Market Report 2026

Global Outlook – By Treatment Type (Immune Checkpoint Inhibitors (ICIs), Combination Therapy), By Indication (Endometrial, Gastric, Colorectal Cancer, Small Intestine Cancer, Cervical Cancer, Other Indications), By Stage (Early Stages, Advanced Stages), By End User (Hospitals, Oncology Clinics, Research Institutions, Homecare) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

MSI-H And dMMR Market Overview

• MSI-H And dMMR market size has reached to $7.57 billion in 2025

• Expected to grow to $21.13 billion in 2030 at a compound annual growth rate (CAGR) of 22.7%

• Growth Driver: Rising Prevalence Of Cancer Is Fueling The Market Due To Increasing Demand For Personalized Immunotherapy Approaches

• Market Trend: Innovative Combination Therapies Transforming MSI-H And dMMR Cancer Treatment

• North America was the largest region in 2025.

What Is Covered Under MSI-H And dMMR Market?

MSI-H (microsatellite instability-high) and dMMR (deficient mismatch repair) refer to genetic abnormalities where the DNA repair system fails to correct replication errors, leading to high mutation rates. These markers are commonly found in certain cancers, such as colorectal and endometrial. Tumors with MSI-H and dMMR often respond well to immunotherapy due to their high immunogenicity.

The main treatment types for MSI-H and dMMR include immune checkpoint inhibitors (ICIs) and combination therapies. Immune checkpoint inhibitors are drugs that enhance the immune system's ability to fight cancer by blocking proteins such as PD-1, PD-L1, or CTLA-4, which tumors use to suppress immune responses. These treatments are used across various indications, including endometrial cancer, gastric cancer, colorectal cancer, small intestine cancer, cervical cancer, and other indications, and are applicable across different cancer stages, including early stages and advanced stages. These therapies are administered in various settings, such as hospitals, oncology clinics, research institutions, and homecare environments.

MSI-H And dMMR Market Global Report 2026 Market Report bar graph

What Is The MSI-H And dMMR Market Size and Share 2026?

The msi-h and dmmr market size has grown exponentially in recent years. It will grow from $7.57 billion in 2025 to $9.32 billion in 2026 at a compound annual growth rate (CAGR) of 23.1%. The growth in the historic period can be attributed to discovery of msi-h and dmmr biomarkers, early success of immune checkpoint inhibitors, rising colorectal and endometrial cancer incidence, expansion of molecular diagnostics, regulatory approvals for biomarker-based therapies.

What Is The MSI-H And dMMR Market Growth Forecast?

The msi-h and dmmr market size is expected to see exponential growth in the next few years. It will grow to $21.13 billion in 2030 at a compound annual growth rate (CAGR) of 22.7%. The growth in the forecast period can be attributed to growth in precision oncology adoption, increasing use of genomic testing in cancer care, expansion of immunotherapy indications, rising investment in biomarker research, growing clinical evidence supporting tumor-agnostic approaches. Major trends in the forecast period include increasing adoption of immunotherapy for msi-h and dmmr tumors, growing use of companion diagnostics for patient stratification, rising focus on tumor-agnostic cancer treatments, expansion of combination immunotherapy regimens, increasing awareness of biomarker-driven oncology.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

Global MSI-H And dMMR Market Segmentation

1) By Treatment Type: Immune Checkpoint Inhibitors (ICIs), Combination Therapy

2) By Indication: Endometrial, Gastric, Colorectal Cancer, Small Intestine Cancer, Cervical Cancer, Other Indications

3) By Stage: Early Stages, Advanced Stages

4) By End User: Hospitals, Oncology Clinics, Research Institutions, Homecare

Subsegments:

1) By Immune Checkpoint Inhibitors (ICIs): Programmed Cell Death Protein 1 Inhibitors, Programmed Cell Death Ligand 1 Inhibitors, Cytotoxic T-Lymphocyte Antigen 4 Inhibitors

2) By Combination Therapy: Immune Checkpoint Inhibitor + Chemotherapy, Immune Checkpoint Inhibitor + Targeted Therapy, Immune Checkpoint Inhibitor + Radiation Therapy, Immune Checkpoint Inhibitor + Other Immunotherapies

What Is The Driver Of The MSI-H And dMMR Market?

The rising prevalence of cancer is expected to propel the growth of the MSI-H and dMMR market going forward. Cancer refers to a group of diseases characterized by the uncontrolled growth and spread of abnormal cells in the body. The rising prevalence of cancer is primarily due to aging populations, as the risk of developing cancer increases significantly with age because of the cumulative effect of genetic mutations and prolonged exposure to risk factors over time. MSI-H and dMMR are used in cancer to identify tumors with high mutation rates due to defects in DNA repair mechanisms. These biomarkers help guide immunotherapy decisions, as such tumors are more likely to respond to immune checkpoint inhibitors, and they also provide insight into prognosis and potential genetic syndromes. For instance, in January 2024, according to the American Cancer Society, a US-based non-profit organization, in 2023, an estimated 1,958,310 new cancer cases and 609,820 cancer-related deaths were expected in the United States. These numbers are projected to rise in 2024, with approximately 2,001,140 new cancer cases and 611,720 deaths anticipated, highlighting a continuing increase in cancer incidence and mortality. Therefore, the rising prevalence of cancer is driving the growth of the MSI-H and dMMR industry.

Key Players In The Global MSI-H And dMMR Market

Major companies operating in the msi-h and dmmr market are Pfizer Inc., F. Hoffmann-La Roche Ltd, Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis International AG, AstraZeneca PLC, Bristol-Myers Squibb Company, GSK plc., Takeda Pharmaceutical Company, Incyte Corporation, Exact Sciences Corp., BeiGene LTD., Summit Therapeutics Inc., Tempus Labs Inc., Guardant Health, NeoGenomics Laboratories Inc., Promega Corporation, Caris Life Sciences, and Owkin.

Global MSI-H And dMMR Market Trends and Insights

Major companies operating in the MSI-H and dMMR market are focusing on developing innovative treatments, such as combination therapy, to enhance treatment efficacy and improve patient outcomes. Combination therapy for MSI-H and dMMR cancers involves using two or more treatment modalities, commonly immunotherapy agents such as checkpoint inhibitors or combining immunotherapy with chemotherapy, targeted therapy, or radiation. This approach aims to enhance treatment response, overcome resistance, and improve survival outcomes in patients with tumors that exhibit high microsatellite instability or deficient mismatch repair. For instance, in April 2025, Bristol-Myers Squibb Company, a US-based pharmaceutical company, received United States Food and Drug Administration (FDA) approval for the combination of nivolumab (Opdivo) and ipilimumab (Yervoy) as a first-line treatment for metastatic colorectal cancer (mCRC) with microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR) features, further advancing treatment options for this challenging cancer subtype. This approval marks a significant milestone in the treatment of MSI-H and dMMR cancers, as it provides a new, effective therapeutic option that targets multiple pathways to improve patient survival and response rates, addressing the unmet medical needs in this patient population.

Need data on a specific region in this market?
Request Regional Data

What Are Latest Mergers And Acquisitions In The MSI-H And dMMR Market?

In December 2023, Owkin Inc., a France-based company specializing in AI-driven drug discovery and precision medicine, partnered with Merck & Co. Inc. to develop AI-powered digital pathology diagnostics for cancer. This collaboration aims to enhance MSI-H testing rates across various cancer types in the EU market, including endometrial, gastric, small intestinal, and biliary cancers, by leveraging artificial intelligence to improve diagnostic accuracy, streamline laboratory workflows, and better match patients with appropriate treatments. Merck & Co. Inc. is a US-based pharmaceutical company that focuses on providing KEYTRUDA (pembrolizumab) for adult and pediatric patients with unresectable or metastatic microsatellite instability-high (MSI-H) cancer.

Regional Insights

North America was the largest region in the MSI-H and dMMR market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the MSI-H And dMMR Market?

The MSI-H and dMMR market consists of revenues earned by entities by providing services such as genetic and molecular diagnostic testing, personalized treatment planning, and immunotherapy administration. The market value includes the value of related goods sold by the service provider or included within the service offering. The MSI-H and dMMR market consists of sales of bispecific antibodies, monoclonal antibodies, and oncolytic virus therapy. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the MSI-H And dMMR Market Report 2026?

The msi-h and dmmr market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the msi-h and dmmr industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

MSI-H And dMMR Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $9.32 billion
Revenue Forecast In 2035 $21.13 billion
Growth Rate CAGR of 23.1% from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Treatment Type, Indication, Stage, End User
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled Pfizer Inc., F. Hoffmann-La Roche Ltd, Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis International AG, AstraZeneca PLC, Bristol-Myers Squibb Company, GSK plc., Takeda Pharmaceutical Company, Incyte Corporation, Exact Sciences Corp., BeiGene LTD., Sum
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. MSI-H And dMMR Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global MSI-H And dMMR Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. MSI-H And dMMR Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global MSI-H And dMMR Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Industry 4.0 & Intelligent Manufacturing

4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.2. Major Trends

4.2.1 Increasing Adoption Of Immunotherapy For Msi-H And Dmmr Tumors

4.2.2 Growing Use Of Companion Diagnostics For Patient Stratification

4.2.3 Rising Focus On Tumor-Agnostic Cancer Treatments

4.2.4 Expansion Of Combination Immunotherapy Regimens

4.2.5 Increasing Awareness Of Biomarker-Driven Oncology

5. MSI-H And dMMR Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Oncology Clinics

5.3 Diagnostic Laboratories

5.4 Research Institutions

5.5 Cancer Genomics Centers

6. MSI-H And dMMR Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global MSI-H And dMMR Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global MSI-H And dMMR PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global MSI-H And dMMR Market Size, Comparisons And Growth Rate Analysis

7.3. Global MSI-H And dMMR Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global MSI-H And dMMR Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global MSI-H And dMMR Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. MSI-H And dMMR Market Segmentation

9.1. Global MSI-H And dMMR Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Immune Checkpoint Inhibitors (ICIs), Combination Therapy

9.2. Global MSI-H And dMMR Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Endometrial, Gastric, Colorectal Cancer, Small Intestine Cancer, Cervical Cancer, Other Indications

9.3. Global MSI-H And dMMR Market, Segmentation By Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Early Stages, Advanced Stages

9.4. Global MSI-H And dMMR Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals, Oncology Clinics, Research Institutions, Homecare

9.5. Global MSI-H And dMMR Market, Sub-Segmentation Of Immune Checkpoint Inhibitors (ICIs), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Programmed Cell Death Protein 1 Inhibitors, Programmed Cell Death Ligand 1 Inhibitors, Cytotoxic T-Lymphocyte Antigen 4 Inhibitors

9.6. Global MSI-H And dMMR Market, Sub-Segmentation Of Combination Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Immune Checkpoint Inhibitor + Chemotherapy, Immune Checkpoint Inhibitor + Targeted Therapy, Immune Checkpoint Inhibitor + Radiation Therapy, Immune Checkpoint Inhibitor + Other Immunotherapies

10. MSI-H And dMMR Market Regional And Country Analysis

10.1. Global MSI-H And dMMR Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global MSI-H And dMMR Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific MSI-H And dMMR Market

11.1. Asia-Pacific MSI-H And dMMR Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific MSI-H And dMMR Market, Segmentation By Treatment Type, Segmentation By Indication, Segmentation By Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China MSI-H And dMMR Market

12.1. China MSI-H And dMMR Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China MSI-H And dMMR Market, Segmentation By Treatment Type, Segmentation By Indication, Segmentation By Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India MSI-H And dMMR Market

13.1. India MSI-H And dMMR Market, Segmentation By Treatment Type, Segmentation By Indication, Segmentation By Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan MSI-H And dMMR Market

14.1. Japan MSI-H And dMMR Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan MSI-H And dMMR Market, Segmentation By Treatment Type, Segmentation By Indication, Segmentation By Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia MSI-H And dMMR Market

15.1. Australia MSI-H And dMMR Market, Segmentation By Treatment Type, Segmentation By Indication, Segmentation By Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia MSI-H And dMMR Market

16.1. Indonesia MSI-H And dMMR Market, Segmentation By Treatment Type, Segmentation By Indication, Segmentation By Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea MSI-H And dMMR Market

17.1. South Korea MSI-H And dMMR Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. South Korea MSI-H And dMMR Market, Segmentation By Treatment Type, Segmentation By Indication, Segmentation By Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan MSI-H And dMMR Market

18.1. Taiwan MSI-H And dMMR Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

18.2. Taiwan MSI-H And dMMR Market, Segmentation By Treatment Type, Segmentation By Indication, Segmentation By Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia MSI-H And dMMR Market

19.1. South East Asia MSI-H And dMMR Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

19.2. South East Asia MSI-H And dMMR Market, Segmentation By Treatment Type, Segmentation By Indication, Segmentation By Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe MSI-H And dMMR Market

20.1. Western Europe MSI-H And dMMR Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

20.2. Western Europe MSI-H And dMMR Market, Segmentation By Treatment Type, Segmentation By Indication, Segmentation By Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK MSI-H And dMMR Market

21.1. UK MSI-H And dMMR Market, Segmentation By Treatment Type, Segmentation By Indication, Segmentation By Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany MSI-H And dMMR Market

22.1. Germany MSI-H And dMMR Market, Segmentation By Treatment Type, Segmentation By Indication, Segmentation By Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France MSI-H And dMMR Market

23.1. France MSI-H And dMMR Market, Segmentation By Treatment Type, Segmentation By Indication, Segmentation By Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy MSI-H And dMMR Market

24.1. Italy MSI-H And dMMR Market, Segmentation By Treatment Type, Segmentation By Indication, Segmentation By Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain MSI-H And dMMR Market

25.1. Spain MSI-H And dMMR Market, Segmentation By Treatment Type, Segmentation By Indication, Segmentation By Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe MSI-H And dMMR Market

26.1. Eastern Europe MSI-H And dMMR Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Eastern Europe MSI-H And dMMR Market, Segmentation By Treatment Type, Segmentation By Indication, Segmentation By Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia MSI-H And dMMR Market

27.1. Russia MSI-H And dMMR Market, Segmentation By Treatment Type, Segmentation By Indication, Segmentation By Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America MSI-H And dMMR Market

28.1. North America MSI-H And dMMR Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

28.2. North America MSI-H And dMMR Market, Segmentation By Treatment Type, Segmentation By Indication, Segmentation By Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA MSI-H And dMMR Market

29.1. USA MSI-H And dMMR Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

29.2. USA MSI-H And dMMR Market, Segmentation By Treatment Type, Segmentation By Indication, Segmentation By Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada MSI-H And dMMR Market

30.1. Canada MSI-H And dMMR Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

30.2. Canada MSI-H And dMMR Market, Segmentation By Treatment Type, Segmentation By Indication, Segmentation By Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America MSI-H And dMMR Market

31.1. South America MSI-H And dMMR Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

31.2. South America MSI-H And dMMR Market, Segmentation By Treatment Type, Segmentation By Indication, Segmentation By Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil MSI-H And dMMR Market

32.1. Brazil MSI-H And dMMR Market, Segmentation By Treatment Type, Segmentation By Indication, Segmentation By Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East MSI-H And dMMR Market

33.1. Middle East MSI-H And dMMR Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

33.2. Middle East MSI-H And dMMR Market, Segmentation By Treatment Type, Segmentation By Indication, Segmentation By Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa MSI-H And dMMR Market

34.1. Africa MSI-H And dMMR Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

34.2. Africa MSI-H And dMMR Market, Segmentation By Treatment Type, Segmentation By Indication, Segmentation By Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. MSI-H And dMMR Market Regulatory and Investment Landscape

36. MSI-H And dMMR Market Competitive Landscape And Company Profiles

36.1. MSI-H And dMMR Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. MSI-H And dMMR Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. MSI-H And dMMR Market Company Profiles

36.3.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.4. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Bayer AG Overview, Products and Services, Strategy and Financial Analysis

37. MSI-H And dMMR Market Other Major And Innovative Companies

Novartis International AG, AstraZeneca PLC, Bristol-Myers Squibb Company, GSK plc., Takeda Pharmaceutical Company, Incyte Corporation, Exact Sciences Corp., BeiGene LTD., Summit Therapeutics Inc., Tempus Labs Inc., Guardant Health, NeoGenomics Laboratories Inc., Promega Corporation, Caris Life Sciences, Owkin

38. Global MSI-H And dMMR Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The MSI-H And dMMR Market

40. MSI-H And dMMR Market High Potential Countries, Segments and Strategies

40.1 MSI-H And dMMR Market In 2030 - Countries Offering Most New Opportunities

40.2 MSI-H And dMMR Market In 2030 - Segments Offering Most New Opportunities

40.3 MSI-H And dMMR Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global MSI-H And dMMR Market, Overview Of Key Products - Product Examples
  • Table 2: Global MSI-H And dMMR Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global MSI-H And dMMR Market, Supply Chain Analysis
  • Table 4: Global MSI-H And dMMR Market, Major Raw Material Providers
  • Table 5: Global MSI-H And dMMR Market, Major Resource Providers
  • Table 6: Global MSI-H And dMMR Market, Major Manufacturers (Suppliers)
  • Table 7: Global MSI-H And dMMR Market, Major Distributors And Channel Partners
  • Table 8: Global MSI-H And dMMR Market, Key Technologies & Future Trends
  • Table 9: Global MSI-H And dMMR Market, Major Trends
  • Table 10: Global MSI-H And dMMR Market, Major End Users
  • Table 11: Global MSI-H And dMMR Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global MSI-H And dMMR Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global MSI-H And dMMR Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global MSI-H And dMMR Market - TAM, US$ Billion, 2025
  • Table 15: Global MSI-H And dMMR Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global MSI-H And dMMR Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global MSI-H And dMMR Market, Segmentation By Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global MSI-H And dMMR Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global MSI-H And dMMR Market, Sub-Segmentation Of Immune Checkpoint Inhibitors (ICIs), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Global MSI-H And dMMR Market, Sub-Segmentation Of Combination Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Global MSI-H And dMMR Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Global MSI-H And dMMR Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: Asia-Pacific, MSI-H And dMMR Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: Asia-Pacific, MSI-H And dMMR Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: Asia-Pacific, MSI-H And dMMR Market, Segmentation By Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: China, MSI-H And dMMR Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: China, MSI-H And dMMR Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: China, MSI-H And dMMR Market, Segmentation By Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: India, MSI-H And dMMR Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: India, MSI-H And dMMR Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: India, MSI-H And dMMR Market, Segmentation By Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: Japan, MSI-H And dMMR Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: Japan, MSI-H And dMMR Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: Japan, MSI-H And dMMR Market, Segmentation By Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: Australia, MSI-H And dMMR Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: Australia, MSI-H And dMMR Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: Australia, MSI-H And dMMR Market, Segmentation By Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: Indonesia, MSI-H And dMMR Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Indonesia, MSI-H And dMMR Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: Indonesia, MSI-H And dMMR Market, Segmentation By Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: South Korea, MSI-H And dMMR Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: South Korea, MSI-H And dMMR Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: South Korea, MSI-H And dMMR Market, Segmentation By Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: Taiwan, MSI-H And dMMR Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: Taiwan, MSI-H And dMMR Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: Taiwan, MSI-H And dMMR Market, Segmentation By Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: South East Asia, MSI-H And dMMR Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: South East Asia, MSI-H And dMMR Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: South East Asia, MSI-H And dMMR Market, Segmentation By Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: Western Europe, MSI-H And dMMR Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: Western Europe, MSI-H And dMMR Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: Western Europe, MSI-H And dMMR Market, Segmentation By Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: UK, MSI-H And dMMR Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: UK, MSI-H And dMMR Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: UK, MSI-H And dMMR Market, Segmentation By Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: Germany, MSI-H And dMMR Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: Germany, MSI-H And dMMR Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: Germany, MSI-H And dMMR Market, Segmentation By Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: France, MSI-H And dMMR Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: France, MSI-H And dMMR Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: France, MSI-H And dMMR Market, Segmentation By Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: Italy, MSI-H And dMMR Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: Italy, MSI-H And dMMR Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: Italy, MSI-H And dMMR Market, Segmentation By Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: Spain, MSI-H And dMMR Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Spain, MSI-H And dMMR Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Spain, MSI-H And dMMR Market, Segmentation By Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Eastern Europe, MSI-H And dMMR Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Eastern Europe, MSI-H And dMMR Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Eastern Europe, MSI-H And dMMR Market, Segmentation By Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Russia, MSI-H And dMMR Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: Russia, MSI-H And dMMR Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 73: Russia, MSI-H And dMMR Market, Segmentation By Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 74: North America, MSI-H And dMMR Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 75: North America, MSI-H And dMMR Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 76: North America, MSI-H And dMMR Market, Segmentation By Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 77: USA, MSI-H And dMMR Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 78: USA, MSI-H And dMMR Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 79: USA, MSI-H And dMMR Market, Segmentation By Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 80: Canada, MSI-H And dMMR Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 81: Canada, MSI-H And dMMR Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 82: Canada, MSI-H And dMMR Market, Segmentation By Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 83: South America, MSI-H And dMMR Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 84: South America, MSI-H And dMMR Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 85: South America, MSI-H And dMMR Market, Segmentation By Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 86: Brazil, MSI-H And dMMR Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 87: Brazil, MSI-H And dMMR Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 88: Brazil, MSI-H And dMMR Market, Segmentation By Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 89: Middle East, MSI-H And dMMR Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 90: Middle East, MSI-H And dMMR Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 91: Middle East, MSI-H And dMMR Market, Segmentation By Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 92: Africa, MSI-H And dMMR Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 93: Africa, MSI-H And dMMR Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 94: Africa, MSI-H And dMMR Market, Segmentation By Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 95: Global MSI-H And dMMR Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 96: Global MSI-H And dMMR Market - Company Scoring Matrix
  • Table 97: Pfizer Inc. Financial Performance
  • Table 98: F. Hoffmann-La Roche Ltd Financial Performance
  • Table 99: Merck & Co. Inc. Financial Performance
  • Table 100: AbbVie Inc. Financial Performance
  • Table 101: Bayer AG Financial Performance
  • Table 102: Global MSI-H And dMMR Market, Competitive Benchmarking (In USD Billions)
  • Table 103: Global MSI-H And dMMR Market, Competitive Dashboard
  • Table 104: Global MSI-H And dMMR Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 105: Global, MSI-H And dMMR Market Size Gain ($ Billion), Segmentation By Treatment Type, 2025 – 2030
  • Table 106: Global, MSI-H And dMMR Market Size Gain ($ Billion), Segmentation By Indication, 2025 – 2030
  • Table 107: Global, MSI-H And dMMR Market Size Gain ($ Billion), Segmentation By Stage, 2025 – 2030

List Of Figures

    Figure 1: Global MSI-H And dMMR Market, Overview Of Key Products - Product Examples
  • Figure 2: Global MSI-H And dMMR Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global MSI-H And dMMR Market, Supply Chain Analysis
  • Figure 4: Global MSI-H And dMMR Market, Major Raw Material Providers
  • Figure 5: Global MSI-H And dMMR Market, Major Resource Providers
  • Figure 6: Global MSI-H And dMMR Market, Major Manufacturers (Suppliers)
  • Figure 7: Global MSI-H And dMMR Market, Major Distributors And Channel Partners
  • Figure 8: Global MSI-H And dMMR Market, Key Technologies & Future Trends
  • Figure 9: Global MSI-H And dMMR Market, Major Trends
  • Figure 10: Global MSI-H And dMMR Market, Major End Users
  • Figure 11: Global MSI-H And dMMR Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global MSI-H And dMMR Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global MSI-H And dMMR Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global MSI-H And dMMR Market - TAM, US$ Billion, 2025
  • Figure 15: Global MSI-H And dMMR Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global MSI-H And dMMR Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global MSI-H And dMMR Market, Segmentation By Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global MSI-H And dMMR Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global MSI-H And dMMR Market, Sub-Segmentation Of Immune Checkpoint Inhibitors (ICIs), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Global MSI-H And dMMR Market, Sub-Segmentation Of Combination Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Global MSI-H And dMMR Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Global MSI-H And dMMR Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: Asia-Pacific, MSI-H And dMMR Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: Asia-Pacific, MSI-H And dMMR Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: Asia-Pacific, MSI-H And dMMR Market, Segmentation By Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: China, MSI-H And dMMR Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: China, MSI-H And dMMR Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: China, MSI-H And dMMR Market, Segmentation By Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: India, MSI-H And dMMR Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: India, MSI-H And dMMR Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: India, MSI-H And dMMR Market, Segmentation By Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: Japan, MSI-H And dMMR Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: Japan, MSI-H And dMMR Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: Japan, MSI-H And dMMR Market, Segmentation By Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: Australia, MSI-H And dMMR Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: Australia, MSI-H And dMMR Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: Australia, MSI-H And dMMR Market, Segmentation By Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: Indonesia, MSI-H And dMMR Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Indonesia, MSI-H And dMMR Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: Indonesia, MSI-H And dMMR Market, Segmentation By Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: South Korea, MSI-H And dMMR Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: South Korea, MSI-H And dMMR Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: South Korea, MSI-H And dMMR Market, Segmentation By Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: Taiwan, MSI-H And dMMR Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: Taiwan, MSI-H And dMMR Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: Taiwan, MSI-H And dMMR Market, Segmentation By Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: South East Asia, MSI-H And dMMR Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: South East Asia, MSI-H And dMMR Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: South East Asia, MSI-H And dMMR Market, Segmentation By Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: Western Europe, MSI-H And dMMR Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: Western Europe, MSI-H And dMMR Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: Western Europe, MSI-H And dMMR Market, Segmentation By Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: UK, MSI-H And dMMR Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: UK, MSI-H And dMMR Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: UK, MSI-H And dMMR Market, Segmentation By Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: Germany, MSI-H And dMMR Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: Germany, MSI-H And dMMR Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: Germany, MSI-H And dMMR Market, Segmentation By Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: France, MSI-H And dMMR Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: France, MSI-H And dMMR Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: France, MSI-H And dMMR Market, Segmentation By Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: Italy, MSI-H And dMMR Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: Italy, MSI-H And dMMR Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: Italy, MSI-H And dMMR Market, Segmentation By Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: Spain, MSI-H And dMMR Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Spain, MSI-H And dMMR Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Spain, MSI-H And dMMR Market, Segmentation By Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Eastern Europe, MSI-H And dMMR Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Eastern Europe, MSI-H And dMMR Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Eastern Europe, MSI-H And dMMR Market, Segmentation By Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Russia, MSI-H And dMMR Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: Russia, MSI-H And dMMR Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 73: Russia, MSI-H And dMMR Market, Segmentation By Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 74: North America, MSI-H And dMMR Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 75: North America, MSI-H And dMMR Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 76: North America, MSI-H And dMMR Market, Segmentation By Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 77: USA, MSI-H And dMMR Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 78: USA, MSI-H And dMMR Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 79: USA, MSI-H And dMMR Market, Segmentation By Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 80: Canada, MSI-H And dMMR Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 81: Canada, MSI-H And dMMR Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 82: Canada, MSI-H And dMMR Market, Segmentation By Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 83: South America, MSI-H And dMMR Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 84: South America, MSI-H And dMMR Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 85: South America, MSI-H And dMMR Market, Segmentation By Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 86: Brazil, MSI-H And dMMR Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 87: Brazil, MSI-H And dMMR Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 88: Brazil, MSI-H And dMMR Market, Segmentation By Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 89: Middle East, MSI-H And dMMR Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 90: Middle East, MSI-H And dMMR Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 91: Middle East, MSI-H And dMMR Market, Segmentation By Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 92: Africa, MSI-H And dMMR Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 93: Africa, MSI-H And dMMR Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 94: Africa, MSI-H And dMMR Market, Segmentation By Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 95: Global MSI-H And dMMR Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 96: Global MSI-H And dMMR Market - Company Scoring Matrix
  • Figure 97: Pfizer Inc. Financial Performance
  • Figure 98: F. Hoffmann-La Roche Ltd Financial Performance
  • Figure 99: Merck & Co. Inc. Financial Performance
  • Figure 100: AbbVie Inc. Financial Performance
  • Figure 101: Bayer AG Financial Performance
  • Figure 102: Global MSI-H And dMMR Market, Competitive Benchmarking (In USD Billions)
  • Figure 103: Global MSI-H And dMMR Market, Competitive Dashboard
  • Figure 104: Global MSI-H And dMMR Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 105: Global, MSI-H And dMMR Market Size Gain ($ Billion), Segmentation By Treatment Type, 2025 – 2030
  • Figure 106: Global, MSI-H And dMMR Market Size Gain ($ Billion), Segmentation By Indication, 2025 – 2030
  • Figure 107: Global, MSI-H And dMMR Market Size Gain ($ Billion), Segmentation By Stage, 2025 – 2030

Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Read More About Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

Read More About Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Read More About 2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

Read More About Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

Read More About A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

A 2025 market overview covering growth forecasts, treatment landscape, and key stakeholders in the isovaleric acidemia treatment market.

Read More About A 2025 market overview covering growth forecasts, treatment landscape, and key stakeholders in the isovaleric acidemia treatment market.

A dynamic 2025 report outlining growth drivers, pipeline innovations, and key markets in liver cancer therapeutics.

Read More About A dynamic 2025 report outlining growth drivers, pipeline innovations, and key markets in liver cancer therapeutics.

A 2025 analysis tracking API pricing, competitive landscape, and growth strategies in the losartan potassium active pharmaceutical ingredient market.

Read More About A 2025 analysis tracking API pricing, competitive landscape, and growth strategies in the losartan potassium active pharmaceutical ingredient market.

Automotive Human Machine Interface (HMI) Market Report 2026 - Global Outlook – By Product Type (Voice Control, Central Display, Instrument Cluster, Steering Mounted Control, Rear-Seat Entertainment (RSE) Display, Heads-U...

Electronic Data Interchange (EDI) Software Market Report 2026 - Global Outlook – By Component (Software, Services), By Deployment (On-Premise, Cloud Based), By Organization Size (Small And Medium-Sized Enterprises, Large...

Digital Aerospace MRO Market Report 2026 - Global Outlook – By Technology (Predictive Maintenance, AR Or VR, 3D Printing, Artificial Intelligence, Internet Of Things, Robotics, Others ), By Application (Inspection, Perfo...

Digital Audio Workstation (DAW) Software Market Report 2026 - Global Outlook – By Type (Macintosh (MAC), Windows, Other Types), By Pricing Model (Subscription, One Time Purchase), By Application (Professional Or Audio En...

Real-Time PCR, Digital PCR And End-Point PCR Market Report 2026 - Global Outlook – By Product (Instruments, Consumables And Reagents, Software And Services), By Technology (Quantitative, End-Point Polymerase Chain Reacti...

Multiplex PCR Assays Market Report 2026 - Global Outlook – By Assay Type (Planar Assay, Bead Based Assay), By Product And Services (Consumables, Instruments, Software And Services), By Application (Disease Diagnosis, Res...

Healthcare EDI Market Report 2026 - Global Outlook – By Component (Software, Services), By Transaction (Claim Management, Healthcare Supply Chain, Other Transactions), By Mode of Delivery (VAN, Web And Cloud-based, Point...

Data Center Interconnect (DCI) Market Report 2026 - Global Outlook – By Type (Products, Software, Services), By Application (Disaster Recovery And Business Continuity, Shared Data And Resources, Data (Storage) Mobility, ...

Frequently Asked Questions

The MSI-H And dMMR market was valued at $7.57 billion in 2025, increased to $9.32 billion in 2026, and is projected to reach $21.13 billion by 2030.

The global MSI-H And dMMR market is expected to grow at a CAGR of 22.7% from 2026 to 2035 to reach $21.13 billion by 2035.

Some Key Players in the MSI-H And dMMR market Include, Pfizer Inc., F. Hoffmann-La Roche Ltd, Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis International AG, AstraZeneca PLC, Bristol-Myers Squibb Company, GSK plc., Takeda Pharmaceutical Company, Incyte Corporation, Exact Sciences Corp., BeiGene LTD., Summit Therapeutics Inc., Tempus Labs Inc., Guardant Health, NeoGenomics Laboratories Inc., Promega Corporation, Caris Life Sciences, and Owkin. .

Major trend in this market includes: Innovative Combination Therapies Transforming MSI-H And dMMR Cancer Treatment. For further insights on this market. request a sample here

North America was the largest region in the MSI-H and dMMR market in 2025. The regions covered in the msi-h and dmmr market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us